Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
RIGHT Choice 最终结果：瑞博西尼联合内分泌治疗与联合化疗治疗绝经前临床侵袭性激素受体阳性/人表皮生长因子受体 2 阴性晚期乳腺癌患者的疗效比较
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00144
Lu, Yen-Shen; Mahidin, Eznal Izwadi Bin Mohd; Azim, Hamdy; Eralp, Yesim; Yap, Yoon Sim; Im, Seock-Ah; Rihani, Julie; Gokmen, Erhan; El Bastawisy, Ahmed; Karadurmus, Nuri; Lim, Yueh Ni; Lim, Chun Sen; Duc, Le Thanh; Chung, Wei-Pang; Babu, K Govind; Penkov, Konstantin; Bowles, James; Alfaro, Teresa Delgar; Wu, Jiwen; Gao, Melissa; Slimane, Khemaies; El Saghir, Nagi S
